Improving Prognosis for Patients With Early Prostate Cancer: Innovations in Surgery, Radiotherapy, and Immunotherapy
27th Apr 2006, 17:21 GMT
Using techniques such as prostatectomy, node sampling, and biopsy, and coupling radiation therapy with immune-response approaches, investigators are predicting disease-free response in the treatment of early prostate cancer with a high degree of certainty. (CME) Medscape Hematology-Oncology Hossein Jadvar
Improving Prognosis for Patients With Early Prostate Cancer: Innovations in Surgery, Radiotherapy, and Immunotherapy related news:
- Planning and Assessment of New Prostate Cancer Therapies — Medscape Radiology Headlines
- New test predicts return of prostate cancer — The Cancer Blog
- Hormonal and Bone-Targeted Therapies for Patients With Advanced Prostate Cancer: Recent Advances — Medscape Radiology Headlines
- Chemotherapy and Novel Agents for Patients With Advanced Prostate Cancer: New Developments — Medscape Radiology Headlines
- Late-Stage Prostate Cancer: The Emergence of Promising Interventions — Medscape Radiology Headlines
- 2nd Annual Multidisciplinary Prostate Cancer Symposium — Medscape Radiology Headlines
- Choice of chemotherapy before liver metastasis surgery matters for some patients — EurekAlert! - Cancer
- Almost 1/3 of colon cancer patients stop chemotherapy, leading to double the death rate — EurekAlert! - Breaking News
- Epstein Reviews Recommendations For Rebiopsy In Patients With High Grade Pin Or Atypical Foci In Prostate Biopsy — Medical News Today RSS/XML Feed
- Prostate cancer services cause concern — The Irish Times' Irish Top Stories